Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-15-002867
Filing Date
2015-12-17
Accepted
2015-12-17 16:54:57
Documents
71
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q vygr-20150930x10q.htm 10-Q 2035411
2 EX-31.1 vygr-20150930ex3119282f3.htm EX-31.1 18767
3 EX-31.2 vygr-20150930ex312832911.htm EX-31.2 18957
4 EX-32.1 vygr-20150930ex32110ee81.htm EX-32.1 14823
  Complete submission text file 0001558370-15-002867.txt   7931090

Data Files

Seq Description Document Type Size
5 EX-101.INS vygr-20150930.xml EX-101.INS 1606856
6 EX-101.SCH vygr-20150930.xsd EX-101.SCH 63203
7 EX-101.CAL vygr-20150930_cal.xml EX-101.CAL 52279
8 EX-101.DEF vygr-20150930_def.xml EX-101.DEF 278284
9 EX-101.LAB vygr-20150930_lab.xml EX-101.LAB 497932
10 EX-101.PRE vygr-20150930_pre.xml EX-101.PRE 428050
Mailing Address 75 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 75 SIDNEY STREET CAMBRIDGE MA 02139 857-259-5340
Voyager Therapeutics, Inc. (Filer) CIK: 0001640266 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37625 | Film No.: 151294254
SIC: 2836 Biological Products, (No Diagnostic Substances)